Bank of New York Mellon’s AtriCure ATRC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.95M | Buy |
141,275
+10,625
| +8% | +$299K | ﹤0.01% | 2576 |
|
|
2026
Q1 | $3.73M | Sell |
130,650
-4,922
| -4% | -$168K | ﹤0.01% | 2480 |
|
|
2025
Q4 | $5.36M | Sell |
135,572
-18,485
| -12% | -$678K | ﹤0.01% | 2282 |
|
|
2025
Q3 | $5.43M | Buy |
154,057
+2,042
| +1% | +$70.4K | ﹤0.01% | 2261 |
|
|
2025
Q2 | $4.98M | Sell |
152,015
-101,178
| -40% | -$3.29M | ﹤0.01% | 2269 |
|
|
2025
Q1 | $8.17M | Sell |
253,193
-5,079
| -2% | -$189K | ﹤0.01% | 1957 |
|
|
2024
Q4 | $7.89M | Buy |
258,272
+6,809
| +3% | +$219K | ﹤0.01% | 2041 |
|
|
2024
Q3 | $7.05M | Sell |
251,463
-42,223
| -14% | -$1.04M | ﹤0.01% | 2113 |
|
|
2024
Q2 | $6.69M | Sell |
293,686
-12,298
| -4% | -$284K | ﹤0.01% | 2179 |
|
|
2024
Q1 | $9.31M | Buy |
305,984
+57,270
| +23% | +$1.92M | ﹤0.01% | 1995 |
|
|
2023
Q4 | $8.88M | Sell |
248,714
-40,858
| -14% | -$1.52M | ﹤0.01% | 2040 |
|
|
2023
Q3 | $12.7M | Sell |
289,572
-678
| -0.2% | -$33.1K | ﹤0.01% | 1802 |
|
|
2023
Q2 | $14.3M | Sell |
290,250
-4,061
| -1% | -$187K | ﹤0.01% | 1748 |
|
|
2023
Q1 | $12.2M | Sell |
294,311
-2,683
| -0.9% | -$111K | ﹤0.01% | 1826 |
|
|
2022
Q4 | $13.2M | Sell |
296,994
-7,697
| -3% | -$322K | ﹤0.01% | 1779 |
|
|
2022
Q3 | $11.9M | Buy |
304,691
+37,682
| +14% | +$1.72M | ﹤0.01% | 1806 |
|
|
2022
Q2 | $10.9M | Buy |
267,009
+5,135
| +2% | +$243K | ﹤0.01% | 1884 |
|
|
2022
Q1 | $17.2M | Sell |
261,874
-167,529
| -39% | -$10.9M | ﹤0.01% | 1764 |
|
|
2021
Q4 | $29.9M | Buy |
429,403
+168,693
| +65% | +$12.3M | 0.01% | 1483 |
|
|
2021
Q3 | $18.1M | Sell |
260,710
-5,619
| -2% | -$432K | ﹤0.01% | 1784 |
|
|
2021
Q2 | $21.1M | Buy |
266,329
+3,319
| +1% | +$241K | ﹤0.01% | 1705 |
|
|
2021
Q1 | $17.2M | Sell |
263,010
-66,240
| -20% | -$4.08M | ﹤0.01% | 1786 |
|
|
2020
Q4 | $18.3M | Buy |
329,250
+34,785
| +12% | +$1.5M | ﹤0.01% | 1688 |
|
|
2020
Q3 | $11.7M | Sell |
294,465
-20,523
| -7% | -$870K | ﹤0.01% | 1775 |
|
|
2020
Q2 | $14.2M | Sell |
314,988
-21,232
| -6% | -$924K | ﹤0.01% | 1646 |
|
|
2020
Q1 | $11.3M | Buy |
336,220
+14,014
| +4% | +$504K | ﹤0.01% | 1629 |
|
|
2019
Q4 | $10.5M | Buy |
322,206
+8,681
| +3% | +$247K | ﹤0.01% | 1945 |
|
|
2019
Q3 | $7.82M | Sell |
313,525
-4,565
| -1% | -$130K | ﹤0.01% | 2061 |
|
|
2019
Q2 | $9.49M | Buy |
318,090
+119,500
| +60% | +$3.49M | ﹤0.01% | 1990 |
|
|
2019
Q1 | $5.32M | Sell |
198,590
-25,777
| -11% | -$783K | ﹤0.01% | 2305 |
|
|
2018
Q4 | $6.87M | Sell |
224,367
-13,333
| -6% | -$415K | ﹤0.01% | 2113 |
|
|
2018
Q3 | $8.33M | Sell |
237,700
-10,816
| -4% | -$342K | ﹤0.01% | 2132 |
|
|
2018
Q2 | $6.72M | Buy |
248,516
+46,920
| +23% | +$1.1M | ﹤0.01% | 2233 |
|
|
2018
Q1 | $4.14M | Sell |
201,596
-980
| -0.5% | -$17.7K | ﹤0.01% | 2447 |
|
|
2017
Q4 | $3.69M | Sell |
202,576
-697
| -0.3% | -$13.8K | ﹤0.01% | 2497 |
|
|
2017
Q3 | $4.55M | Buy |
203,273
+3,580
| +2% | +$80.9K | ﹤0.01% | 2374 |
|
|
2017
Q2 | $4.84M | Buy |
199,693
+20,107
| +11% | +$427K | ﹤0.01% | 2344 |
|
|
2017
Q1 | $3.44M | Buy |
179,586
+35,013
| +24% | +$613K | ﹤0.01% | 2524 |
|
|
2016
Q4 | $2.83M | Buy |
144,573
+7,738
| +6% | +$140K | ﹤0.01% | 2647 |
|
|
2016
Q3 | $2.17M | Buy |
136,835
+2,598
| +2% | +$39.9K | ﹤0.01% | 2713 |
|
|
2016
Q2 | $1.9M | Buy |
134,237
+4,302
| +3% | +$65.6K | ﹤0.01% | 2737 |
|
|
2016
Q1 | $2.19M | Buy |
129,935
+3,176
| +3% | +$55.9K | ﹤0.01% | 2601 |
|
|
2015
Q4 | $2.85M | Sell |
126,759
-27,685
| -18% | -$571K | ﹤0.01% | 2513 |
|
|
2015
Q3 | $3.38M | Sell |
154,444
-38,191
| -20% | -$954K | ﹤0.01% | 2440 |
|
|
2015
Q2 | $4.75M | Buy |
192,635
+16,872
| +10% | +$377K | ﹤0.01% | 2385 |
|
|
2015
Q1 | $3.6M | Buy |
175,763
+41,478
| +31% | +$804K | ﹤0.01% | 2490 |
|
|
2014
Q4 | $2.68M | Sell |
134,285
-6,507
| -5% | -$112K | ﹤0.01% | 2661 |
|
|
2014
Q3 | $2.07M | Buy |
140,792
+7,126
| +5% | +$114K | ﹤0.01% | 2852 |
|
|
2014
Q2 | $2.46M | Buy |
133,666
+17,607
| +15% | +$293K | ﹤0.01% | 2778 |
|
|
2014
Q1 | $2.18M | Buy |
116,059
+23,893
| +26% | +$490K | ﹤0.01% | 2820 |
|
|
2013
Q4 | $1.72M | Buy |
92,166
+7,982
| +9% | +$116K | ﹤0.01% | 2973 |
|
|
2013
Q3 | $924K | Buy |
84,184
+6,279
| +8% | +$61.9K | ﹤0.01% | 3286 |
|
|
2013
Q2 | $740K | Buy |
+77,905
| New | +$679K | ﹤0.01% | 3345 |
|
Other funds holding ATRC
PAM
WA
NC
RHJA
Bank of New York Mellon's ATRC Position: Q2 2026 in Review
Bank of New York Mellon increased its AtriCure (ATRC) stake by 8.1% in Q2 2026, buying an estimated $299K and bringing the position to 141,275 shares worth $3.95M. The position accounts for ﹤0.01% of the portfolio, ranked #2576.
Bank of New York Mellon first reported a position in ATRC in Q2 2013 and has held it in 53 quarters since. The position peaked at $29.9M in Q4 2021. 78 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.
- Bank of New York Mellon held 141,275 shares of AtriCure worth $3.95M as of Q2 2026.
- Bank of New York Mellon bought 10,625 AtriCure shares in Q2 2026, an estimated $299K.
- AtriCure made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #2576 holding.
- Bank of New York Mellon first reported a position in AtriCure in Q2 2013 and has held it in 53 quarters since.
- Bank of New York Mellon's AtriCure position peaked at $29.9M in Q4 2021.
- 78 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.
Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.